Table 2.
Outcomes of IPF therapy for severe ulcerative colitis, number (percentage)
| Outcome | Induction phase | Medium-term period | |
|---|---|---|---|
| At 6 weeks (n = 17) | At 3 months (n = 14) | At 1 year ( n = 12)a | |
| Remission | 13 (76) | 13 (93)b | 9 (75)b |
| Response without remission | 2 (12) | NA | NA |
| Colectomy | 1 (6) | 0 (0) | 0 (0) |
| Failure | 1 (6) | NA | NA |
| Relapse | NA | 0 (0) | 3 (25) |
| Corticosteroid treatment | NA | 1 (7) | 0 (0) |
| Corticosteroid dependence | NA | 0 (0) | 0 (0) |
| Death | 0 (0) | 0 (0) | 0 (0) |
a Two follow-up cases are not included because their follow-up periods were less than 1 y.
b Three cases of scheduled infliximab maintenance therapy in each subgroup are included.
IPF = infliximab and plant-based diet as first-line (therapy); NA = not applicable.